Development and Implementation of an Exercise Prescription Protocol for Lung Cancer Patients Using Internet-Connected Fitness Trackers
2015
- 157Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage157
- Abstract Views157
Artifact Description
Rationale: Lung cancer and its treatment often result in high symptom burden and reduced quality of life [QoL]. Recently, exercise has been recognized as an effective therapy for the disease, and fitness trackers offer a cheap, objective way of measuring this activity. However, feasibility of such data collection among lung cancer patients needs to be established.Methods: Forty-three patients with Stage III/IV lung cancer were approached at MUSC’s Combined Thoracic Oncology clinic. Participants were given surveys assessing dyspnea, QoL, and depression, and ten agreed to wear a Fitbit Zip® to collect their step counts for seven days. Associations between survey domains and average daily step counts were assessed using Spearman rank correlations.Results: Forty of 43 patients [93%] participated, and all approached participants agreed to wear Fitbit® pedometers and returned them with usable step counts. Positive correlations with step counts were noted for physical, social, role, and emotional functioning as well as QoL. Negative correlations were observed with pain, constipation, breathlessness, and insomnia.Conclusions: Despite high symptom burden, this cohort’s high participation rate, low survey completion time, and 100% activity data collection confirms study feasibility. Active patients with advanced lung cancer report greater overall QoL, suggesting exercise as a therapeutic target in advanced-stage lung cancer.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know